N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole

C69H82Cl5N19O9S3 — CID 158000251

IUPACN-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole
SMILESCC(=O)N1CC2CC1CN2c1cc(Cl)cc2[nH]ncc12.CS(=O)(=O)N1CC2CC1CN2c1cc(Cl)cc2[nH]ncc12.CS(=O)(=O)NC1CCC(c2cc(Cl)cc3[nH]ncc23)CC1.C[C@H]1CN(S(C)(=O)=O)CCN1c1cc(Cl)cc2[nH]ncc12.O=C(C1COC1)N1CCN(c2cc(Cl)cc3[nH]ncc23)CC1
InChIInChI=1S/C15H17ClN4O2.C14H15ClN4O.C14H18ClN3O2S.C13H15ClN4O2S.C13H17ClN4O2S/c16-11-5-13-12(7-17-18-13)14(6-11)19-1-3-20(4-2-19)15(21)10-8-22-9-10;1-8(20)18-6-11-4-10(18)7-19(11)14-3-9(15)2-13-12(14)5-16-17-13;1-21(19,20)18-11-4-2-9(3-5-11)12-6-10(15)7-14-13(12)8-16-17-14;1-21(19,20)18-7-9-4-10(18)6-17(9)13-3-8(14)2-12-11(13)5-15-16-12;1-9-8-17(21(2,19)20)3-4-18(9)13-6-10(14)5-12-11(13)7-15-16-12/h5-7,10H,1-4,8-9H2,(H,17,18);2-3,5,10-11H,4,6-7H2,1H3,(H,16,17);6-9,11,18H,2-5H2,1H3,(H,16,17);2-3,5,9-10H,4,6-7H2,1H3,(H,15,16);5-7,9H,3-4,8H2,1-2H3,(H,15,16)/t;;;;9-/m....0/s1
InChIKeyFDQMHGOFFAYTTJ-OJQYEMAUSA-N
MW1595.00 g/mol
LogP9.45
Rot. Bonds10

About N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole

N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole (PubChem CID 158000251) has the molecular formula C69H82Cl5N19O9S3 and a molecular weight of 1595.00 g/mol. Its IUPAC name is N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole.

Molecular Properties

Compound NameN-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole
PubChem CID158000251
Molecular FormulaC69H82Cl5N19O9S3
Molecular Weight1595.00 g/mol
Exact Mass1591.41
IUPAC NameN-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole
SMILESCC(=O)N1CC2CC1CN2c1cc(Cl)cc2[nH]ncc12.CS(=O)(=O)N1CC2CC1CN2c1cc(Cl)cc2[nH]ncc12.CS(=O)(=O)NC1CCC(c2cc(Cl)cc3[nH]ncc23)CC1.C[C@H]1CN(S(C)(=O)=O)CCN1c1cc(Cl)cc2[nH]ncc12.O=C(C1COC1)N1CCN(c2cc(Cl)cc3[nH]ncc23)CC1
InChIInChI=1S/C15H17ClN4O2.C14H15ClN4O.C14H18ClN3O2S.C13H15ClN4O2S.C13H17ClN4O2S/c16-11-5-13-12(7-17-18-13)14(6-11)19-1-3-20(4-2-19)15(21)10-8-22-9-10;1-8(20)18-6-11-4-10(18)7-19(11)14-3-9(15)2-13-12(14)5-16-17-13;1-21(19,20)18-11-4-2-9(3-5-11)12-6-10(15)7-14-13(12)8-16-17-14;1-21(19,20)18-7-9-4-10(18)6-17(9)13-3-8(14)2-12-11(13)5-15-16-12;1-9-8-17(21(2,19)20)3-4-18(9)13-6-10(14)5-12-11(13)7-15-16-12/h5-7,10H,1-4,8-9H2,(H,17,18);2-3,5,10-11H,4,6-7H2,1H3,(H,16,17);6-9,11,18H,2-5H2,1H3,(H,16,17);2-3,5,9-10H,4,6-7H2,1H3,(H,15,16);5-7,9H,3-4,8H2,1-2H3,(H,15,16)/t;;;;9-/m....0/s1
InChIKeyFDQMHGOFFAYTTJ-OJQYEMAUSA-N
XLogP9.45
TPSA327.14 Ų
H-Bond Donors6
H-Bond Acceptors18
Rotatable Bonds10
Heavy Atoms105
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001595.00
LogP ≤ 59.45
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1018

Analyze N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole?
The IUPAC name of N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole (CID 158000251) is N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole.
What is the SMILES notation for N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole?
The canonical SMILES for N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole is CC(=O)N1CC2CC1CN2c1cc(Cl)cc2[nH]ncc12.CS(=O)(=O)N1CC2CC1CN2c1cc(Cl)cc2[nH]ncc12.CS(=O)(=O)NC1CCC(c2cc(Cl)cc3[nH]ncc23)CC1.C[C@H]1CN(S(C)(=O)=O)CCN1c1cc(Cl)cc2[nH]ncc12.O=C(C1COC1)N1CCN(c2cc(Cl)cc3[nH]ncc23)CC1.
What is the InChIKey of N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole?
The InChIKey is FDQMHGOFFAYTTJ-OJQYEMAUSA-N. The full InChI is InChI=1S/C15H17ClN4O2.C14H15ClN4O.C14H18ClN3O2S.C13H15ClN4O2S.C13H17ClN4O2S/c16-11-5-13-12(7-17-18-13)14(6-11)19-1-3-20(4-2-19)15(21)10-8-22-9-10;1-8(20)18-6-11-4-10(18)7-19(11)14-3-9(15)2-13-12(14)5-16-17-13;1-21(19,20)18-11-4-2-9(3-5-11)12-6-10(15)7-14-13(12)8-16-17-14;1-21(19,20)18-7-9-4-10(18)6-17(9)13-3-8(14)2-12-11(13)5-15-16-12;1-9-8-17(21(2,19)20)3-4-18(9)13-6-10(14)5-12-11(13)7-15-16-12/h5-7,10H,1-4,8-9H2,(H,17,18);2-3,5,10-11H,4,6-7H2,1H3,(H,16,17);6-9,11,18H,2-5H2,1H3,(H,16,17);2-3,5,9-10H,4,6-7H2,1H3,(H,15,16);5-7,9H,3-4,8H2,1-2H3,(H,15,16)/t;;;;9-/m....0/s1.
What are the key properties of N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole?
N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole has a molecular weight of 1595.00 g/mol, XLogP of 9.45, 10 rotatable bonds, 6 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;1-[5-(6-chloro-1H-indazol-4-yl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethanone;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole is sourced from PubChem (CID 158000251), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).